Guideline for postmarketing Chinese medicine pharmacoeconomic evaluation / 中国结合医学杂志
Chinese journal of integrative medicine
;
(12): 473-480, 2015.
Article
in English
| WPRIM
| ID: wpr-262680
ABSTRACT
Pharmacoeconomics is an important part of the postmarketing Chinese medicine (CM) evaluation, and postmarketing pharmacoeconomic evaluation can reveal the clinical and market value of CM. The purpose of establishing the guideline for pharmacoeconomic evaluation is to make the evaluation process and results regarding Chinese patent medicines both scientific and fair. Every country's guidelines for pharmacoeconomic evaluation act as reference guidelines, we have already drawn up the guideline that takes into account the special characteristics of CM; and these are in preparation for the postmarketing CM pharmacoeconomic evaluation.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Product Surveillance, Postmarketing
/
Pharmaceutical Preparations
/
Statistics as Topic
/
Clinical Trials as Topic
/
Cost-Benefit Analysis
/
Guidelines as Topic
/
Economics, Pharmaceutical
/
Economics
Type of study:
Evaluation studies
/
Practice guideline
/
Health economic evaluation
Limits:
Humans
Language:
English
Journal:
Chinese journal of integrative medicine
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS